Metanalyses on metformin's role in pancreatic cancer suffer from severe bias and low data quality – An umbrella review-Reference-Cited by-同舟云学术

Metanalyses on metformin's role in pancreatic cancer suffer from severe bias and low data quality – An umbrella review

Published:2023-03 Issue:2 Volume:23 Page:192-200
ISSN:1424-3903
Container-title:Pancreatology
language:en
Short-container-title:Pancreatology

Author:

Nowicka Zuzanna^ORCID,Matyjek Anna^ORCID,Płoszka Katarzyna^ORCID,Łaszczych Mateusz,Fendler Wojciech

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Endocrinology, Diabetes and Metabolism

Reference45 articles.

1. Cancer statistics;Siegel,2021

2. Pancreatic cancer;Mizrahi;Lancet,2020

3. Metformin antagonizes cancer cell proliferation by suppressing mitochondrial-dependent biosynthesis;Griss;PLoS Biol. Public Library of Science,2015

4. Metformin causes cancer cell death through downregulation of p53-dependent differentiated embryo chondrocyte 1;Hsieh Li;J Biomed Sci,2018

5. Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling;Feng;Cell Death Dis. Nature Publishing Group,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peroxisome proliferator-activated receptors: Key regulators of tumor progression and growth;Translational Oncology;2024-09

2. Metformin boosts antitumor immunity and improves prognosis in upfront resected pancreatic cancer: an observational study;JNCI: Journal of the National Cancer Institute;2024-03-26

3. Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study);Discover Oncology;2023-06-06